{"DataElement":{"publicId":"11325685","version":"1","preferredName":"Diagnosis Tumor Grade","preferredDefinition":"A text term to express the degree of abnormality of cancer cells as a measure of differentiation and aggressiveness.","longName":"11323463v1.00:11323466v1.00","context":"CRDC","contextVersion":"1","DataElementConcept":{"publicId":"11323463","version":"1","preferredName":"Diagnosis Tumor Grade","preferredDefinition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.:The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems.","longName":"2442484v1.00:11323462v1.00","context":"CRDC","contextVersion":"1","ObjectClass":{"publicId":"2442484","version":"1","preferredName":"Diagnosis","preferredDefinition":"The process of identifying a disease by the signs and symptoms.","longName":"C15220","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"09046428-50E1-6C1D-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-01-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-01-04","modifiedBy":"ONEDATA","dateModified":"2006-01-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2427327","version":"1","preferredName":"Grade","preferredDefinition":"Describes how closely a cancer resembles normal tissue of its same type, and the cancer's probable rate of growth","longName":"C18000","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic Grade","conceptCode":"C18000","definition":"The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05116195-EBA8-7341-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-09","modifiedBy":"ONEDATA","dateModified":"2005-11-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CRDC:Cancer Research Data Commons","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E9A99875-0A7D-181C-E053-731AD00A00F0","latestVersionIndicator":"Yes","beginDate":"2022-09-27","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-09-27","modifiedBy":"COLBERTM","dateModified":"2022-10-16","changeDescription":null,"administrativeNotes":"10/16/22 Released per CRDC DSS. mr; \r\n10/4/22 Edited long name. mr; \r\n10/2 & 10/3/22 Edited concepts. mr;\r\n9/27/22 Created for CRDC RFC 26. mr;","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"11323466","version":"1","preferredName":"Tumor Grade","preferredDefinition":"The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems._A position on a scale of intensity or amount or quality.","longName":"11323466v1.00","context":"CRDC","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"G1","valueDescription":null,"ValueMeaning":{"publicId":"10987208","version":"1","preferredName":"Well Differentiated","longName":"10987208v1.00","preferredDefinition":"Describes tumor cells that generally retain the appearance of normal cells and tend to grow and spread at a slower rate than undifferentiated or poorly differentiated tumor cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Well Differentiated","conceptCode":"C14171","definition":"Describes tumor cells that generally retain the appearance of normal cells and tend to grow and spread at a slower rate than undifferentiated or poorly differentiated tumor cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E58921BD-D078-61B9-E053-731AD00A8871","latestVersionIndicator":"Yes","beginDate":"2022-08-05","endDate":null,"createdBy":"RAGUNATHANU","dateCreated":"2022-08-05","modifiedBy":"RAGUNATHANU","dateModified":"2022-08-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E9A9D09E-5EB9-26A3-E053-731AD00AB421","beginDate":"2022-09-27","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-09-27","modifiedBy":"COLBERTM","dateModified":"2022-09-27","deletedIndicator":"No"},{"value":"G2","valueDescription":null,"ValueMeaning":{"publicId":"4614616","version":"1","preferredName":"Moderately Differentiated","longName":"4614616","preferredDefinition":"Describes tumor cells that have lost some of the appearance of normal cells. They tend to grow and spread at a faster rate than well differentiated tumor cells. ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Moderately Differentiated","conceptCode":"C14162","definition":"Describes tumor cells that have lost some of the appearance of normal cells. They tend to grow and spread at a faster rate than well differentiated tumor cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"08ED0A2A-987A-C182-E050-BB89AD436A0C","latestVersionIndicator":"Yes","beginDate":"2014-11-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-11-28","modifiedBy":"LISU","dateModified":"2022-08-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E9A9D09E-5EBA-26A3-E053-731AD00AB421","beginDate":"2022-09-27","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-09-27","modifiedBy":"COLBERTM","dateModified":"2022-09-27","deletedIndicator":"No"},{"value":"G3","valueDescription":null,"ValueMeaning":{"publicId":"5424651","version":"1","preferredName":"Poorly Differentiated","longName":"5424651","preferredDefinition":"Describes tumor cells that generally have lost most of the appearance of normal cells. They tend to grow and spread.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Poorly Differentiated","conceptCode":"C14167","definition":"Describes tumor cells that generally have lost most of the appearance of normal cells. They tend to grow and spread.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3A68DC6A-DED6-1436-E050-BB89AD43184D","latestVersionIndicator":"Yes","beginDate":"2016-08-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-08-19","modifiedBy":"LISU","dateModified":"2022-08-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E9A9D09E-5EBB-26A3-E053-731AD00AB421","beginDate":"2022-09-27","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-09-27","modifiedBy":"COLBERTM","dateModified":"2022-09-27","deletedIndicator":"No"},{"value":"GX","valueDescription":null,"ValueMeaning":{"publicId":"10987209","version":"1","preferredName":"Grade X","longName":"10987209v1.00","preferredDefinition":"A morphologic qualifier indicating that the grade of a neoplasm cannot be assessed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Grade X","conceptCode":"C113730","definition":"A morphologic qualifier indicating that the grade of a neoplasm cannot be assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5892CDB-26A1-62C6-E053-731AD00A9902","latestVersionIndicator":"Yes","beginDate":"2022-08-05","endDate":null,"createdBy":"RAGUNATHANU","dateCreated":"2022-08-05","modifiedBy":"RAGUNATHANU","dateModified":"2022-08-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E9A9D09E-5EBC-26A3-E053-731AD00AB421","beginDate":"2022-09-27","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-09-27","modifiedBy":"COLBERTM","dateModified":"2022-09-27","deletedIndicator":"No"},{"value":"High Grade","valueDescription":null,"ValueMeaning":{"publicId":"3288211","version":"1","preferredName":"High Grade","longName":"3288211","preferredDefinition":"Used to describe tumor samples that exhibit poorly differentiated or undifferentiated cells. They are generally expected to be fast growing and aggressive.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"High Grade","conceptCode":"C14158","definition":"Used to describe tumor samples that exhibit poorly differentiated or undifferentiated cells. They are generally expected to be fast growing and aggressive.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE6DC488-B15F-8FD1-E040-BB89AD432EE0","latestVersionIndicator":"Yes","beginDate":"2011-10-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E9A9D09E-5EBE-26A3-E053-731AD00AB421","beginDate":"2022-09-27","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-09-27","modifiedBy":"COLBERTM","dateModified":"2022-09-27","deletedIndicator":"No"},{"value":"Intermediate Grade","valueDescription":null,"ValueMeaning":{"publicId":"3335158","version":"1","preferredName":"Intermediate Grade","longName":"3335158","preferredDefinition":"A term referring to the degree of differentiation of a malignant neoplasm and indicating that it is moderately differentiated.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intermediate Grade","conceptCode":"C28083","definition":"A term referring to the degree of differentiation of a malignant neoplasm and indicating that it is moderately differentiated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B43D00DA-4E4B-7AC2-E040-BB89AD434B8C","latestVersionIndicator":"Yes","beginDate":"2011-12-16","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-12-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E9A9D09E-5EBF-26A3-E053-731AD00AB421","beginDate":"2022-09-27","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-09-27","modifiedBy":"COLBERTM","dateModified":"2022-09-27","deletedIndicator":"No"},{"value":"Low Grade","valueDescription":null,"ValueMeaning":{"publicId":"3288210","version":"1","preferredName":"Low Grade","longName":"3288210","preferredDefinition":"Used to describe tumor samples that exhibit well to moderately well differentiated cells. They are generally expected to be slow growing and less aggressive.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Low Grade","conceptCode":"C14161","definition":"Used to describe tumor samples that exhibit well to moderately well differentiated cells. They are generally expected to be slow growing and less aggressive.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE6DC488-B13C-8FD1-E040-BB89AD432EE0","latestVersionIndicator":"Yes","beginDate":"2011-10-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E9A9D09E-5EC0-26A3-E053-731AD00AB421","beginDate":"2022-09-27","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-09-27","modifiedBy":"COLBERTM","dateModified":"2022-09-27","deletedIndicator":"No"},{"value":"Not Applicable","valueDescription":null,"ValueMeaning":{"publicId":"7590024","version":"1","preferredName":"Not Applicable","longName":"7590024","preferredDefinition":"Determination of a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCB96B6E-DDC3-6924-E053-4EBD850AEF18","latestVersionIndicator":"Yes","beginDate":"2021-03-04","endDate":null,"createdBy":"MORENOC","dateCreated":"2021-03-04","modifiedBy":"KUMMEROA","dateModified":"2023-11-29","changeDescription":null,"administrativeNotes":"7/8/22 added alt name of NA for CCTG cjl;","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E9A9D09E-5EC1-26A3-E053-731AD00AB421","beginDate":"2022-09-27","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-09-27","modifiedBy":"COLBERTM","dateModified":"2022-09-27","deletedIndicator":"No"},{"value":"G4","valueDescription":null,"ValueMeaning":{"publicId":"5428031","version":"1","preferredName":"Undifferentiated","longName":"5428031","preferredDefinition":"A term used to describe cells or tissues that do not have specialized (\"mature\") structures or functions. Undifferentiated cancer cells often grow and spread quickly.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Undifferentiated","conceptCode":"C14176","definition":"Describes tumor cells that generally have lost all of the appearance of normal cells. They tend to grow and spread quickly and aggressively.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3AAEF41A-81D2-3BA9-E050-BB89AD435B01","latestVersionIndicator":"Yes","beginDate":"2016-08-22","endDate":null,"createdBy":"MORENOC","dateCreated":"2016-08-22","modifiedBy":"LISU","dateModified":"2022-08-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E9ACA85E-B73C-08DF-E053-731AD00AD253","beginDate":"2022-09-27","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-09-27","modifiedBy":"COLBERTM","dateModified":"2022-09-27","deletedIndicator":"No"},{"value":"GB","valueDescription":null,"ValueMeaning":{"publicId":"6050322","version":"1","preferredName":"Grade B","longName":"6050322","preferredDefinition":"A morphologic qualifier indicating that a neoplasm is of borderline malignancy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Grade B","conceptCode":"C113729","definition":"A morphologic qualifier indicating that a neoplasm is of borderline malignancy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"626082F5-5F7A-7A30-E053-F662850A46F6","latestVersionIndicator":"Yes","beginDate":"2018-01-09","endDate":null,"createdBy":"LUY","dateCreated":"2018-01-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E9ACA85E-B73D-08DF-E053-731AD00AD253","beginDate":"2022-09-27","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-09-27","modifiedBy":"COLBERTM","dateModified":"2022-09-27","deletedIndicator":"No"},{"value":"Not Reported","valueDescription":null,"ValueMeaning":{"publicId":"5612322","version":"1","preferredName":"Not Reported","longName":"5612322v1.00","preferredDefinition":"Not provided or available.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Reported","conceptCode":"C43234","definition":"Not provided or available.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"45340835-3B00-7C78-E053-F662850A44F9","latestVersionIndicator":"Yes","beginDate":"2017-01-03","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-01-03","modifiedBy":"FINCHAMB","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"10/10/23 changed Long Name from \"Not Stated\" to match NCIt Preferred name and current caDSR concept Long Name of \"Not Reported\" per Brenda.Janice . LS","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F7E34644-8159-4DC9-E053-731AD00AF3AC","beginDate":"2023-03-27","endDate":null,"createdBy":"JKNABLE","dateCreated":"2023-03-27","modifiedBy":"JKNABLE","dateModified":"2023-03-27","deletedIndicator":"No"},{"value":"Unknown","valueDescription":null,"ValueMeaning":{"publicId":"5682953","version":"1","preferredName":"Unknown","longName":"5682953","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"498B4645-0FC6-0802-E053-F662850AB305","latestVersionIndicator":"Yes","beginDate":"2017-02-27","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-02-27","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"01B7A46C-C3FB-310A-E063-731AD00A643B","beginDate":"2023-07-30","endDate":null,"createdBy":"JKNABLE","dateCreated":"2023-07-30","modifiedBy":"JKNABLE","dateModified":"2023-07-30","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"5920787","version":"1","preferredName":"Histologic Grade Grade","preferredDefinition":"The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems.:A position on a scale of intensity or amount or quality.","longName":"C18000:C48309","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic Grade","conceptCode":"C18000","definition":"The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Grade","conceptCode":"C48309","definition":"A position on a scale of intensity or amount or quality.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5669984A-4461-048A-E053-F662850A91CB","latestVersionIndicator":"Yes","beginDate":"2017-08-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-10","modifiedBy":"ONEDATA","dateModified":"2017-08-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CRDC:Cancer Research Data Commons","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E9A9AA29-A27F-1A19-E053-731AD00AFA0E","latestVersionIndicator":"Yes","beginDate":"2022-09-27","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-09-27","modifiedBy":"JKNABLE","dateModified":"2023-07-30","changeDescription":null,"administrativeNotes":"7/30/23 added Unknown as PV per Smita's request to support CDA. jk;  3/27/23 added Not Reported PV to support CDS.  jk; 10/16/22 Released per CRDC DSS. mr;  10/2 & 10/3/22 Edited concepts. mr;  9/27/22 Created for CRDC RFC26. mr;","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"10466051","version":"1","longName":"All CRDC Standard Data Elements","context":"CRDC","ClassificationSchemeItems":[{"publicId":"10466054","version":"1","longName":"Diagnosis","context":"CRDC"}]},{"publicId":"11518160","version":"1","longName":"CTDC (Clinical Trial Data Commons)","context":"CRDC","ClassificationSchemeItems":[{"publicId":"14413712","version":"1","longName":"Clinical","context":"CRDC"},{"publicId":"13484615","version":"1","longName":"Cancer Moonshot Biobank","context":"CRDC"}]},{"publicId":"13574489","version":"1","longName":"Childhood Cancer Data Initiative","context":"Pediatric Cancer","ClassificationSchemeItems":[{"publicId":"13596043","version":"1","longName":"Sample","context":"Pediatric Cancer"},{"publicId":"13596241","version":"1","longName":"Diagnosis","context":"Pediatric Cancer"},{"publicId":"13594093","version":"1","longName":"Sample","context":"Pediatric Cancer"}]},{"publicId":"8064110","version":"1","longName":"CDS (Cancer Data Service)","context":"CRDC","ClassificationSchemeItems":[{"publicId":"12177497","version":"1","longName":"Diagnosis","context":"CRDC"},{"publicId":"14470388","version":"1","longName":"Imaging","context":"CRDC"}]}],"AlternateNames":[{"name":"Tumor Grade","type":"CRDC Alt Name","context":"CRDC"},{"name":"tumor_grade","type":"CDS Alt Name","context":"CRDC"},{"name":"tumor_grade","type":"CCDI Alt Name","context":"Pediatric Cancer"},{"name":"Tumor Grade","type":"CMB Alt Name","context":"CRDC"},{"name":"tumor_grade","type":"CTDC Alt Name","context":"CRDC"}],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"Tumor Grade","url":null,"context":"CRDC"}],"origin":"CRDC:Cancer Research Data Commons","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"E9AA6E7A-AB6A-38BC-E053-731AD00A460C","latestVersionIndicator":"Yes","beginDate":"2022-09-27","endDate":null,"createdBy":"COLBERTM","dateCreated":"2022-09-27","modifiedBy":"JKNABLE","dateModified":"2023-12-31","changeDescription":null,"administrativeNotes":"12/31/23 Added CDS Imaging CSI. jk; 8/7/23 Added Alt Name for CDE with source of “DSS” in the CTDC data model. BF;1/23/23 Added alt name, CDS CSI per CDS metadata template. mr;  10/16/22 Released per email from Wendy Ver Hoef 10/14/22 6:08pm. mr;  \r\n10/2/22 Edited concepts in DEC and VD. mr;  9/27/22 Created for CRDC RFC26.mr","unresolvedIssues":null,"deletedIndicator":"No"}}